Neo Ivy Capital Management increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) by 3,547.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,356 shares of the company’s stock after purchasing an additional 21,743 […]
Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) Director William M. Sullivan sold 12,115 shares of the business’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $24.44, for a total transaction of $296,090.60. Following the completion of the sale, the director now directly owns 5,661,746 shares […]
Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) Director William M. Sullivan sold 12,115 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $24.44, for a total value of $296,090.60. Following the completion of the sale, the director now owns 5,661,746 […]
Advisory Research Inc. reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) by 44.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 54,933 shares of the company’s stock after selling 43,396 shares during the period. Advisory […]
Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) has been given a consensus rating of “Buy” by the sixteen analysts that are currently covering the company, Marketbeat.com reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have updated their coverage on the stock […]